Andere Sprachen RxSight, Inc.

Aktien

A3CWDW

US78349D1072

RXST

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
56,7 ^USD	+8,77 %		+3,24 %	+40,62 %

04.04.	RxSight, Inc. kündigt die Markteinführung seiner neuesten Light Adjustable Lens, der LAL+, an und bietet mehrere Präsentationen von Ärzten auf der bevorstehenden ASCRS-Jahrestagung	CI
02.04.	Rxsight-Insider verkauft Aktien im Wert von 997.946 $, laut einer aktuellen SEC-Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

RxSight, Inc. to Present at the Bank of America Healthcare Conference	01.05.
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024	22.04.
RxSight Launches New Light Adjustable Lens Product	04.04.
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	04.04.
RxSight, Inc. Announces Commercial Launch of its Newest Light Adjustable Lens??, the LAL+??, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	04.04.
Rxsight Insider Sold Shares Worth $997,946, According to a Recent SEC Filing	02.04.
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference	27.03.
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference	01.03.
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference	01.03.
RxSight's Q4 Adjusted Loss Narrows, Sales Increase; Reiterates 2024 Revenue Guidance	29.02.
Earnings Flash (RXST) RXSIGHT Reports Q4 Revenue $28.6M, vs. Street Est of $27.9M	28.02.
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	28.02.
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	28.02.
Rxsight, Inc. Reiterates Earnings Guidance for the Full Year 2024	28.02.
RxSight, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
RxSight, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.02.
Rxsight Insider Sold Shares Worth $1,350,000, According to a Recent SEC Filing	16.02.
Rxsight Insider Bought Shares Worth $406,673, According to a Recent SEC Filing	15.02.
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	14.02.
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	14.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen RxSight, Inc.

Aktien

A3CWDW

US78349D1072

RXST

Andere Sprachen

Filter